AAPG: Margin dodolan operasi Ascentage Pharma Group International

Logo grafis Ascentage Pharma (AAPG)

Ascentage Pharma Group is scaling the distribution of oncology drugs in Asia while optimizing R&D costs. The operating margin trend demonstrates current business efficiency, with the indicator standing at -220.00. Patent protection for inhibitors and stringent certification requirements create a robust barrier to entry. Global partnerships with distributors minimize marketing expenses, ensuring capital and a stable cash flow.

AAPG: Margin operasi ascentage.com 25.01.2025 - 19.11.2026

Rincian metrik lan analitis perusahaan Ascentage Pharma (AAPG)

Pambiji fundamental perusahaan:AAPG, Ascentage Pharma
Produk dadi ascentage.com

Ascentage Pharma Group's large-scale R&D investments and the retention of leading oncologists directly impact its operating cost structure. This metric is calculated as the ratio of operating profit to revenue, demonstrating the efficiency of managing production and administrative expenses before taxes and interest. Analyzing this metric allows for an assessment of the business model's sustainability, which is clearly reflected in the operating profit margin trend.

Karo sapa Ascentage Pharma Group saingan

Rentabilitas operasi BeiGene Ltd|Halozyme Therapeutics - Margin bathi operasi|Margin dodolan operasi RVMD (Revolution Medicines Corp)|Margin dodolan operasi cgoncology.com CGON|UroGen Pharma - Margin dodolan operasi|Tingkat bathi operasi BCAX|PSNL - Rentabilitas operasi|Rentabilitas kegiatan operasi Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas operasi|Y-mAbs Therapeutics - Tingkat bathi operasi|AURA (Aura Biosciences Inc) - Margin operasi|Rentabilitas dodolan operasi candeltx.com CADL|Margin operasi ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi operasi|Rentabilitas operasi Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas operasi|TuHURA Biosciences Inc. - Margin operasi|TARA - Margin operasi|FATE (Fate Therapeutics) - Margin dodolan operasi|Margin dodolan operasi Aadi Bioscience, Inc.|Margin dodolan operasi TCRX|Rentabilitas operasi CSBR|Margin operasi XBIT|Rentabilitas kegiatan operasi CEL-SCI Corp.|Rentabilitas operasi ostherapies.com OSTX|RADX: Rentabilitas dodolan miturut bathi operasi|ARTV: Margin dodolan operasi|ANL (Adlai Nortye) - Rentabilitas dodolan miturut bathi operasi|Veru (VERU) - Rentabilitas operasi|Margin dodolan operasi Tempest Therapeutics Inc|Rentabilitas operasi Xilio Therapeutics|Rentabilitas dodolan miturut bathi operasi RENB (Renovaro Inc.)|Rentabilitas operasi Mural Oncology PLC (MURA)|Margin operasi Kairos Pharma (KAPA)|Rentabilitas operasi onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan miturut bathi operasi|CRIS: Margin dodolan operasi|apollomicsinc.com (APLM) - Margin dodolan operasi|THAR: Margin operasi|Margin dodolan operasi Advanced Biomed Inc.|Margin dodolan operasi GNPX|Rentabilitas dodolan miturut bathi operasi CLDI (Calidi Biotherapeutics)|Margin operasi SBFM|Xenetic Biosciences, Inc. - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Salarius Pharmaceuticals SLRX|Margin operasi purple-biotech.com PPBT|AONC - Rentabilitas operasi|BGNE: Rentabilitas operasi|CKPT: Margin operasi|Elevation Oncology - Tingkat bathi operasi|ICAD (iCAD) - Margin operasi|IKNA: Tingkat bathi operasi|Rentabilitas operasi Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Tingkat bathi operasi|Rentabilitas operasi MorphoSys Corporation MOR|NAYA: Rentabilitas dodolan miturut bathi operasi|Ascentage Pharma Group International - Margin operasi